S

Scryb Inc
OTC:SCYRD

Watchlist Manager
Scryb Inc
OTC:SCYRD
Watchlist
Price: 0.083 USD Market Closed
Market Cap: $2.7m

Net Margin

1 886.9%
Current
Improving
by 2 024.4%
vs 3-y average of -137.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
1 886.9%
=
Net Income
CA$6.5m
/
Revenue
CA$346.3k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
1 886.9%
=
Net Income
$6.5m
/
Revenue
CA$346.3k

Peer Comparison

Country Company Market Cap Net
Margin
CA
Scryb Inc
CNSX:SCYB
3.6m CAD
Loading...
US
Abbott Laboratories
NYSE:ABT
192B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
174.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
131.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
112.1B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
59.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
46.4B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.6B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
45.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
39.5B USD
Loading...

Market Distribution

Higher than 99% of companies in Canada
Percentile
99th
Based on 4 909 companies
99th percentile
1 886.9%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

Scryb Inc
Glance View

Market Cap
2.7m USD
Industry
Health Care

Scryb, Inc. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. The company is headquartered in Etobicoke, Ontario. The Company’s platform offers businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The platform adopts across diverse markets, from digital health and diagnostics to cybersecurity and manufacturing. The Company’s cloud-based platform is composed of elements including sensor technology, Internet of things (IoT), predictive analytics, and computer vision. Its portfolio includes Pharmatrac, Fionet, Handheld Diagnostics and Cybeats. Pharmatrac is an artificial intelligence (AI) digital health company that provides insight into medication behavior. Fionet is a data-and-device platform that enables controlled testing and tracking for pandemic response. Handheld Diagnostics brings lab-quality analysis to bedside in critical care situations. Cybeats builds certainty in software security.

SCYRD Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
1 886.9%
=
Net Income
CA$6.5m
/
Revenue
CA$346.3k
What is Scryb Inc's current Net Margin?

The current Net Margin for Scryb Inc is 1 886.9%, which is above its 3-year median of -137.5%.

How has Net Margin changed over time?

Over the last 3 years, Scryb Inc’s Net Margin has increased from -1 667.5% to 1 886.9%. During this period, it reached a low of -2 110.6% on Dec 31, 2022 and a high of 2 785.5% on Mar 31, 2025.

Back to Top